Reliability of Hepatus® for Evaluating Liver Fibrosis in Chronic Hepatitis B

Abstract BackgroundAmong non-invasive strategies available for liver fibrosis assessment, transient elastography is widely used, as it and can be repeated. Hepatus® (Mindray, China) one novel instrument measuring stiffness that now in the market with lower price than its precursor, FibroScan® (Echosens, Paris). MethodIn this cross sectional study, CHB patients single center were recruited consecutively October 2021-December 2021. The examined LSM two instruments visit. first was second Both measurements done by same operator. ResultsA total of 68 enrolled study. Median score 7.6 (5.92-11.88) 7.35 (5.63-11.80) respectively. Spearman rank analysis correlation showed a significant between results ( r= 0.8, p 0.05). number (≥8 kPa) identified 28 (41%) 29 (43%) McNemar test yielded no difference (p= 1.000), Cohen’s kappa measure agreement moderate (κ = 0.789 0.005). ConclusionHepatus® similar FibroScan®, measurement correlated significantly. has potential an alternative tool more economic price. KeywordsHepatus®, elastography, fibrosis,